OLGA GUSKOVA: Open Payments
NPI 1942680517 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 28 payments from 16 companies in 2025. Trend: 2023 $1,597 · 2024 $671 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $186 |
| ABBVIE INC. | 5 | $116 |
| Averitas Pharma Inc. | 2 | $56 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Eisai Inc. | 1 | $33 |
| Boston Scientific Corporation | 1 | $30 |
| UCB, Inc. | 1 | $29 |
| Biogen, Inc. | 1 | $27 |
| Merz Pharmaceuticals, LLC | 1 | $25 |
| Lundbeck LLC | 1 | $24 |
Products named: KESIMPTA, UBRELVY, Leqembi, QUTENZA, Symbravo, QULIPTA, Vercise, Briviact.
Industry payments across NY — which companies pay providers there.
